Portfolio (Quarterly)
Guide ↗
E Fund Management Co., Ltd.
· CIK 0001842296| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 261 | NCLH | NORWEGIAN CRUISE LINE HLDGS | Consumer Cyclical | 24,040.0 | $507K | 0.01% | +424.0 | +1.8% | $21.11 | -21.1% |
| 262 | CTSH | COGNIZANT TECHNOLOGY SOLUTIO | Technology | 13,079.0 | $507K | 0.01% | -15K | -53.7% | $38.73 | +64.6% |
| 263 | HUM | HUMANA INC | Healthcare | 1,268.0 | $504K | 0.01% | -967.0 | -43.3% | $397.22 | -1.2% |
| 264 | COGT | COGENT BIOSCIENCES INC | Healthcare | 12,928.0 | $500K | 0.01% | -3K | -19.7% | $38.70 | -4.2% |
| 265 | SLS | SELLAS LIFE SCIENCES GROUP I | Healthcare | 33,825.0 | $499K | 0.01% | +2K | +7.9% | $14.76 | +3.0% |
| 266 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 11,657.0 | $498K | 0.01% | +2K | +18.3% | $42.68 | +9.3% |
| 267 | CDE | COEUR MNG INC | Basic Materials | 30,464.0 | $497K | 0.01% | -9K | -23.1% | $16.32 | +36.1% |
| 268 | — | CENCORA INC | — | 1,756.0 | $497K | 0.01% | +140.0 | +8.7% | $282.98 | — |
| 269 | TGTX | TG THERAPEUTICS INC | Healthcare | 9,040.0 | $497K | 0.01% | -12K | -56.3% | $54.94 | +1.4% |
| 270 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 5,094.0 | $497K | 0.01% | +1K | +29.8% | $97.48 | +14.4% |
| 271 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 1,323.0 | $492K | 0.01% | -958.0 | -42.0% | $371.67 | -3.8% |
| 272 | BLK | BLACKROCK INC | Financial Services | 511.0 | $491K | 0.01% | -17.0 | -3.2% | $961.56 | +21.4% |
| 273 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 5,407.0 | $489K | 0.01% | -345.0 | -6.0% | $90.46 | -0.6% |
| 274 | NTRA | NATERA INC | Healthcare | 1,798.0 | $488K | 0.01% | -1K | -37.7% | $271.45 | +24.8% |
| 275 | CDW | CDW CORP | Technology | 3,451.0 | $485K | 0.01% | -72.0 | -2.0% | $140.64 | +5.9% |
| 276 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 13,700.0 | $485K | 0.01% | -5K | -28.5% | $35.39 | +6.2% |
| 277 | FITB | FIFTH THIRD BANCORP | Financial Services | 8,515.0 | $480K | 0.01% | NEW | — | $56.37 | -2.7% |
| 278 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 14,334.0 | $479K | 0.01% | -6K | -31.1% | $33.39 | -21.4% |
| 279 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,891.0 | $477K | 0.01% | -2K | -35.5% | $122.58 | +22.0% |
| 280 | VRT | VERTIV HOLDINGS CO | Industrials | 1,422.0 | $476K | 0.01% | -10K | -87.1% | $334.82 | -19.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
68.9%
Consumer Cyclical
12.9%
Communication Services
4.2%
Financial Services
3.9%
Healthcare
3.4%
Industrials
2.5%
Consumer Defensive
2.3%
Utilities
0.8%
Basic Materials
0.6%
Energy
0.4%